Cancer Letters · 2008 · 165 citations · 43 references
MedicineCancer BiologyOncologyCancer ImmunologyTumor ImmunologyTumor MicroenvironmentCancer Molecular PathologyPancreatic CancerPancreatic DiseasesPancreatic PathologyClinical Significance AssessmentMolecular Prognostic MarkersPancreatic Metastases
43
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Dana R. Leach, Matthew F. Krummel, James P. Allison · Science · 1996 · 3.9K citations
Life Sciences, Immunology, Oncology +17
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Yvette Latchman, Clive R. Wood, Tatyana Chernova et al. · Nature Immunology · 2001 · 2.9K citations